Nahdi Medical Company

TADAWUL:4164.SR

132.8 (SAR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SAR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income 260.607232.95182.602222.6276.702262.342138.56264.869287.114247.382150.74259.214240.388206.926166.80693.097270.643294.606
Depreciation & Amortization 175.133161.976158.972152.58149.201157.328149.532157.198145.265144.647151.235137.665145.269137.33199.738134.561129.231129.231
Deferred Income Tax 000000000000000000
Stock Based Compensation 000000000000000000
Change In Working Capital -301.65956.952-149.72189.537-372.911178.063183.075-177.354-107.459154.22986.289-107.825-133.178141.312395.413290.571-309.368-309.368
Accounts Receivables -75.131-43.504-34.52102.695-92.462-13.86978.613-53.41-12.48-5.8340.5564.696-23.578-69.327108.547-2.261-23.822-23.822
Change In Inventory 49.125-352.092-86.9184.471-8.281-203.90177.4324.841-4.507-204.7882.256-23.35388.602-61.653102.06473.222-182.356-182.356
Change In Accounts Payables -195.391505.47110.966-0.647-236.218483.041-15.00453.4112.48494.062-7.952-109.301-182.816343.8060000
Other Working Capital -80.262-52.923-39.2573.018-35.949-87.20742.035-182.195-102.953359.0094.033-84.471-221.78202.965184.802219.61-103.19-103.19
Other Non Cash Items 46.094224.62826.881-14.393-66.03914.98325.97929.22612.25113.356-34.86616.075-79.63617.033-22.015-112.383179.524155.561
Operating Cash Flow 107.089462.428218.734550.324-13.046612.717497.146273.939337.172559.614353.398305.129172.842502.602639.942405.846270.03270.03
Investing Activities:
Investments In Property Plant And Equipment -90.467-100.82-128.406-105.681-75.079-75.344-75.837-78.251-56.35-64.795-77.165-79.544-52.843-96.915-55.438-78.27-81.07-81.07
Acquisitions Net 1.1420.2540.1210.133000.103000.0354.4782.5450.07900000
Purchases Of Investments 00000000000600200-8000000
Sales Maturities Of Investments 000000000000000000
Other Investing Activites -11.614-9.851-8.098-9.249-5.911-7.137-4.14-0.005-0.030.035-1.863598.953187.284-801.1656.929297.415-55.821-55.821
Investing Cash Flow -89.324-100.566-128.285-105.548-75.079-75.344-75.734-78.256-56.38-64.76-72.687523.001147.236-896.915-48.509219.145-136.891-136.891
Financing Activities:
Debt Repayment -58.234-113.471-96.407-89.124-150.557-99.586-106.37-95.986-104.526-110.082-127.008-104.554-74.366-76.139-85.146-65.56600
Common Stock Issued 000000000000000000
Common Stock Repurchased 000000000000000000
Dividends Paid -1.109-388.8910-325-39000-300.300-200-600-4600-2000-167.5-167.5
Other Financing Activities 00-96.407-89.124-540.55700000-127.008-104.5540000-80.407-80.407
Financing Cash Flow -59.343-502.362-96.407-414.124-540.557-99.586-106.37-396.286-104.526-110.082-327.008-704.554-534.366-76.139-285.146-65.566-247.907-247.907
Other Information:
Effect Of Forex Changes On Cash 0.0420.777-0.8280.002-0.0180.396-0.003-0.001-0-0.206-0.0010.003-0.02600000
Net Change In Cash -41.536-139.723-6.78530.654-628.7438.182315.04-200.603176.265384.565-46.298123.579-214.314-470.452306.287559.425-114.768-114.768
Cash At End Of Period 728.404769.94909.662916.447885.7941,514.4941,076.312761.272961.875785.61401.044447.343323.764538.0781,008.53702.243-114.768-114.768